Tiny Cargo provides a novel drug delivery system.
Tiny Cargo provides a novel drug delivery system based on non-immunogenic bovine milk-derived exosomes for protected oral or IV-based delivery of potent therapeutics. They treat ischemic heart disease, gastrointestinal radiation disease, glioblastoma multiforme, and numerous other pathologies.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 3, 2022 | Grant | $216K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Science Foundation
|
Yes | Grant |